• Recruiting

NCT04920084: A Study of a Plant-Based Diet in People With MGUS / Smoldering Myeloma - NUTRIVENTION

Updated: Sep 8

NUTRIVENTION Study


NUTRIVENTION

NCT04920084: A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)


This study will test whether a plant-based diet is practical (feasible) for overweight people with monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). The researchers will decide how practical the diet is by looking at how much weight participants lose and how well they are able to stick to the diet. The researchers will also determine whether the diet is effective in preventing multiple myeloma in participants. In addition, they will look at how safe the plant-based diet is for participants, and see if the diet affects participants' quality of life.


Sponsor: Memorial Sloan Kettering Cancer Center

 

ClinicalTrials.gov Identifier: NCT04920084


Official Title: A Pilot Plant-Based Dietary Intervention in Overweight and Obese Patients With Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) - The Nutrition Prevention (NUTRIVENTION) Study


First Posted : June 9, 2021


https://clinicaltrials.gov/ct2/show/NCT04920084

 

- New York: Memorial Sloan-Kettering Cancer Center New York

 

Locations


United States, New Jersey

United States, New York









Posts Archive